Erythropoietin improves skeletal muscle microcirculation through the activation of enos in a mouse sepsis model

Journal of Trauma - Injury, Infection and Critical Care

Volumn 71, Issue 5 SUPPL.1, 2011, Pages

  Kao, Raymond L C ^a,b,c   Martin, Claudio M ^b,c   Xenocostas, Anargyros ^b,c   Huang, Weixiong ^b,c   Rui, Tao ^b,c  

^a DEPARTMENT OF NATIONAL DEFENCE   (Canada)

^b Divisions of Critical Care   (Canada)

^c UNIVERSITY OF WESTERN ONTARIO   (Canada)

Author keywords

eNOS activation; Erythropoietin; Intravital microscopy; Microcirculation; Nicotinamide adenine dinucleotide (NADH) fluorescence; Sepsis

Indexed keywords

ENDOTHELIAL NITRIC OXIDE SYNTHASE; N(G) NITROARGININE METHYL ESTER; NICOTINAMIDE ADENINE DINUCLEOTIDE; RECOMBINANT ERYTHROPOIETIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BIOENERGY; CAPILLARY DENSITY; CONTROLLED STUDY; DRUG EFFECT; ENDOTHELIUM CELL; ENZYME ACTIVATION; ENZYME ACTIVITY; ENZYME DEFICIENCY; MICROCIRCULATION; MOUSE; NONHUMAN; PERFUSION; PRIORITY JOURNAL; SEPSIS; SINGLE DRUG DOSE; SKELETAL MUSCLE;

ANIMALS; DISEASE MODELS, ANIMAL; ENZYME ACTIVATION; ERYTHROPOIETIN; MICE; MICE, INBRED C57BL; MICROCIRCULATION; MUSCLE, SKELETAL; NITRIC OXIDE SYNTHASE TYPE III; SEPSIS; TREATMENT OUTCOME;

EID: 81455154767     PISSN: 00225282     EISSN: 15298809     Source Type: Journal    
DOI: 10.1097/TA.0b013e318232e7a2     Document Type: Article

References (50)

1. Annane D, Bellissant E, Cavaillon JM. Septic shock. Lancet. 2005;365: 63-78.
2. Sprung CL, Annane D, Keh D, et al; CORTICUS Study Group. Hydrocortisone therapy for patients with septic shock. N Engl J Med. 2008; 358:111-124.
3. Dellinger RP, Levy MM, Carlet JM, et al; International Surviving Sepsis Campaign Guidelines Committee; American Association of Critical-Care Nurses; American College of Chest Physicians; American College of Emergency Physicians; Canadian Critical Care Society; European Society of Clinical Microbiology and Infectious Diseases; European Society of Intensive Care Medicine; European Respiratory Society; International Sepsis Forum; Japanese Association for Acute Medicine; Japanese Society of Intensive Care Medicine; Society of Critical Care Medicine; Society of Hospital Medicine; Surgical Infection Society; World Federation of Societies of Intensive and Critical Care Medicine. Surviving Sepsis Campaign: international guidelines for management of severe sepsis and septic shock: 2008. Crit Care Med. 2008;36:296-327.
4. Cain SM, Curtis SE. Experimental models of pathologic oxygen supply dependency. Crit Care Med. 1991;19:603-612.
5. 2 Collaborative Group. N Engl J Med. 1995;333:1025-1032.
6. Sawada K, Krantz SB, Kans JS, et al. Purification of human erythroid colony-forming units and demonstration of specific binding of erythropoietin. J Clin Invest. 1987;80:357-366.
7. Brines M, Cerami A. Erythropoietin-mediated tissue protection: reducing collateral damage from the primary injury response. J Intern Med. 2008;264:405-432.
8. Mori S, Sawada T, Okada T, Kubota K. Erythropoietin and its derivative protect the intestine from severe ischemia/reperfusion injury in the rat. Surgery. 2008;143:556-565. (Pubitemid 351406385)
9. Guneli E, Cavdar Z, Islekel H, et al. Erythropoietin protects the intestine against ischemia/reperfusion injury in rats. Mol Med. 2007;13:509-517. (Pubitemid 47585745)
10. Palmer RM, Ashton DS, Moncada S. Vascular endothelial cells synthesize nitric oxide from L-arginine. Nature. 1988;333:664-666.
11. Pollock JS, Forstermann U, Mitchell JA, et al. Purification and characterization of particulate endothelium-derived relaxing factor synthase from cultured and native bovine aortic endothelial cells. Proc Natl Acad Sci U S A. 1991;88:10480-10484. (Pubitemid 21915859)
12. Harrison DG. Endothelial dysfunction in atherosclerosis. Basic Res Cardiol. 1994;89(suppl 1):87-102. (Pubitemid 24314600)
13. Ichinose F, Buys ES, Neilan TG, et al. Cardiomyocyte-specific overexpression of nitric oxide synthase 3 prevents myocardial dysfunction in murine models of septic shock. Circ Res. 2007;100:130-139. (Pubitemid 46066781)
14. Tyml K, Li F, Wilson JX. Septic impairment of capillary blood flow requires nicotinamide adenine dinucleotide phosphate oxidase but not nitric oxide synthase and is rapidly reversed by ascorbate through an endothelial nitric oxide synthase-dependent mechanism. Crit Care Med. 2008;36:2355-2362.
15. Bommhardt U, Chang KC, Swanson PE, et al. Akt decreases lymphocyte apoptosis and improves survival in sepsis. J Immunol. 2004;172:7583-7591. (Pubitemid 38747622)
16. Kao R, Xenocostas A, Rui T, et al. Erythropoietin improves skeletal muscle microcirculation and tissue bioenergetics in a mouse sepsis model. Crit Care. 2007;11:R58.
17. Yang M, Wu J, Martin CM, Kvietys PR, Rui T. Important role of p38 MAP kinase/NF-{kappa}B signaling pathway in the sepsis-induced conversion of cardiac myocytes to a proinflammatory phenotype. Am J Physiol Heart Circ Physiol. 2008;294:H994-H1001. (Pubitemid 351253313)
18. Lam C, Tyml K, Martin C, Sibbald W. Microvascular perfusion is impaired in a rat model of normotensive sepsis. J Clin Invest. 1994;94: 2077-2083. (Pubitemid 24348249)
19. Rose J, Martin C, MacDonald T, Ellis C. High-resolution intravital NADH fluorescence microscopy allows measurements of tissue bioenergetics in rat ileal mucosa. Microcirculation. 2006;13:41-47. (Pubitemid 43050889)
20. Rose J, Martin C. Tissue bioenergetics and microvascular perfusion are impaired in rat ileal mucosa in normotensive sepsis. Microcirculation. 2006;13:49-56. (Pubitemid 43050890)
21. Rui T, Feng Q, Lei M, et al. Erythropoietin prevents the acute myocardial inflammatory response induced by ischemia/reperfusion via induction of AP-1. Cardiovasc Res. 2005;65:719-727. (Pubitemid 40138993)
22. Riedemann NC, Guo RF, Ward PA. Novel strategies for the treatment of sepsis. Nat Med. 2003;9:517-524. (Pubitemid 36597096)
23. Uusaro A, Ruokonen E, Takala J. Gastric mucosal pH does not reflect changes in splanchnic blood flow after cardiac surgery. Br J Anaesth. 1995;74:149-154.
24. Madorin WS, Martin CM, Sibbald WJ. Dopexamine attenuates flow motion in ileal mucosal arterioles in normotensive sepsis. Crit Care Med. 1999;27:394-400. (Pubitemid 29113551)
25. Bersten A, Sibbald WJ. Circulatory disturbances in multiple systems organ failure. Crit Care Clin. 1989;5:233-254. (Pubitemid 19111047)
26. Ince C, Sinaasappel M. Microcirculatory oxygenation and shunting in sepsis and shock. Crit Care Med. 1999;27:1369-1377. (Pubitemid 29379377)
27. Savino R, Ciliberto G. A paradigm shift for erythropoietin: no longer a specialized growth factor, but rather an all-purpose tissue-protective agent. Cell Death Differ. 2004;11(suppl 1):S2-S4. (Pubitemid 39136789)
28. Maiese K, Li F, Chong ZZ. New avenues of exploration for erythropoietin. JAMA. 2005;293:90-95. (Pubitemid 40066704)
29. Szabo C, Thiemermann C. Invited opinion: role of nitric oxide in hemorrhagic, traumatic, and anaphylactic shock and thermal injury. Shock. 1994;2:145-155.
30. Bateman RM, Sharpe MD, Ellis CG. Bench-to-bedside review: microvascular dysfunction in sepsis-hemodynamics, oxygen transport, and nitric oxide. Crit Care. 2003;7:359-373. (Pubitemid 37236307)
31. Chandra A, Enkhbaatar P, Nakano Y, Traber LD, Traber DL. Sepsis: emerging role of nitric oxide and selectins. Clinics (Sao Paulo). 2006; 61:71-76.
32. Lehner MD, Marx D, Boer R, et al. In vivo characterization of the novel imidazopyridine BYK191023 [2-[2-(4-methoxy-pyridin-2-yl)-ethyl]-3H-imidazo[4,5- b]pyridine], a potent and highly selective inhibitor of inducible nitric-oxide synthase. J Pharmacol Exp Ther. 2006;317:181-187.
33. Matejovic M, Krouzecky A, Martinkova V, et al. Selective inducible nitric oxide synthase inhibition during long-term hyperdynamic porcine bacteremia. Shock. 2004;21:458-465.
34. Okamoto I, Abe M, Shibata K, et al. Evaluating the role of inducible nitric oxide synthase using a novel and selective inducible nitric oxide synthase inhibitor in septic lung injury produced by cecal ligation and puncture. Am J Respir Crit Care Med. 2000;162:716-722. (Pubitemid 30647224)
35. Squadrito F, Altavilla D, Squadrito G, et al. Recombinant human erythropoietin inhibits iNOS activity and reverts vascular dysfunction in splanchnic artery occlusion shock. Br J Pharmacol. 1999;127:482-488. (Pubitemid 29245687)
36. Akimoto T, Kusano E, Muto S, et al. The effect of erythropoietin on interleukin-1beta mediated increase in nitric oxide synthesis in vascular smooth muscle cells. J Hypertens. 1999;17:1249-1256. (Pubitemid 29509502)
37. Genc K, Genc S, Baskin H, Semin I. Erythropoietin decreases cytotoxicity and nitric oxide formation induced by inflammatory stimuli in rat oligodendrocytes. Physiol Res. 2006;55:33-38. (Pubitemid 43276809)
38. Aoshiba K, Onizawa S, Tsuji T, Nagai A. Therapeutic effects of erythropoietin in murine models of endotoxin shock. Crit Care Med. 2009;37:889-898.
39. d'Uscio LV, Smith LA, Santhanam AV, Richardson D, Nath KA, Katusic ZS. Essential role of endothelial nitric oxide synthase in vascular effects of erythropoietin. Hypertension. 2007;49:1142-1148. (Pubitemid 351664320)
40. Wang XQ, Vaziri ND. Erythropoietin depresses nitric oxide synthase expression by human endothelial cells. Hypertension. 1999;33:894-899. (Pubitemid 29140452)
41. Connelly L, Madhani M, Hobbs AJ. Resistance to endotoxic shock in endothelial nitric-oxide synthase (eNOS) knock-out mice: a proinflammatory role for eNOS-derived no in vivo. J Biol Chem. 2005;280:10040-10046. (Pubitemid 40395855)
42. Wang X, Zhu C, Wang X, et al. The nonerythropoietic asialoerythropoietin protects against neonatal hypoxia-ischemia as potently as erythropoietin. J Neurochem. 2004;91:900-910. (Pubitemid 39507367)
43. McGown CC, Brown NJ, Hellewell PG, Reilly CS, Brookes ZL. Beneficial microvascular and anti-inflammatory effects of pravastatin during sepsis involve nitric oxide synthase III. Br J Anaesth. 2010;104:183-190.
44. Lamontagne F, Meade M, Ondiveeran HK, Lesur O, Robichaud AE. Nitric oxide donors in sepsis: a systematic review of clinical and in vivo preclinical data. Shock. 2008;30:653-659.
45. Bayir H, Kagan VE, Clark RS, et al. Neuronal NOS-mediated nitration and inactivation of manganese superoxide dismutase in brain after experimental and human brain injury. J Neurochem. 2007;101:168-181. (Pubitemid 46426473)
46. Cuong DV, Warda M, Kim N, et al. Dynamic changes in nitric oxide and mitochondrial oxidative stress with site-dependent differential tissue response during anoxic preconditioning in rat heart. Am J Physiol Heart Circ Physiol. 2007;293:H1457-H1465. (Pubitemid 47367189)
47. Connelly L, Jacobs AT, Palacios-Callender M, Moncada S, Hobbs AJ. Macrophage endothelial nitric-oxide synthase autoregulates cellular activation and pro-inflammatory protein expression. J Biol Chem. 2003; 278:26480-26487. (Pubitemid 36876789)
48. Grisham MB, Jourd'heuil D, Wink DA. Nitric oxide. I. Physiological chemistry of nitric oxide and its metabolites: implications in inflammation. Am J Physiol. 1999;276:G315-G321. (Pubitemid 29104144)
49. Burger D, Lei M, Geoghegan-Morphet N, Lu X, Xenocostas A, Feng Q. Erythropoietin protects cardiomyocytes from apoptosis via up-regulation of endothelial nitric oxide synthase. Cardiovasc Res. 2006;72:51-59. (Pubitemid 44310637)
50. Wu WT, Hu TM, Lin NT, Subeq YM, Lee RP, Hsu BG. Low-dose erythropoietin aggravates endotoxin-induced organ damage in conscious rats. Cytokine. 2010;49:155-162.